- To understand how Vericiguat was studied in patients with HFrEF
- To critically assess the utility of Vericiguat in HFrEF and what patient population would benefit from the same.
11/12/2021 - 7:30am to 8:30am CST
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Kifah Hussain, MD